FASN and neoplasm: In addition, fatty acid synthase (FASN) inhibitors such as cerulenin and denifanstat restored the activation of dendritic cells (DCs) and tumor infiltration of effector T-cells in preclinical models and showed good tolerability and partial efficacy in clinical trials (e.g., NCT02980029, NCT03179904 et al).